LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | PF431396 | 0.12 | uM | LJP5 | 72 | hr | 513 | 2639 | 10401 | 0.2537 | 0.2150 |
MCF 10A | PF477736 | 0.12 | uM | LJP5 | 72 | hr | 513 | 8819 | 10401 | 0.8479 | 0.8400 |
MCF 10A | PF562271 | 0.12 | uM | LJP6 | 72 | hr | 513 | 7123 | 10401 | 0.6848 | 0.6685 |
MCF 10A | PHA-665752 | 0.12 | uM | LJP5 | 72 | hr | 513 | 10091 | 10401 | 0.9703 | 0.9687 |
MCF 10A | PHA-793887 | 0.12 | uM | LJP6 | 72 | hr | 513 | 1086 | 10401 | 0.1044 | 0.0579 |
MCF 10A | PI103 | 0.12 | uM | LJP6 | 72 | hr | 513 | 3982 | 10401 | 0.3829 | 0.3509 |
MCF 10A | PLX-4720 | 0.12 | uM | LJP5 | 72 | hr | 513 | 10983 | 10401 | 1.0560 | 1.0589 |
MCF 10A | QL-X-138 | 0.12 | uM | LJP6 | 72 | hr | 513 | 8468 | 10401 | 0.8141 | 0.8045 |
MCF 10A | QL-XII-47 | 0.12 | uM | LJP6 | 72 | hr | 513 | 9154 | 10401 | 0.8801 | 0.8739 |
MCF 10A | Radicicol | 0.12 | uM | LJP5 | 72 | hr | 513 | 1750 | 10401 | 0.1683 | 0.1251 |
MCF 10A | Radicicol | 0.12 | uM | LJP6 | 72 | hr | 513 | 1851 | 10401 | 0.1780 | 0.1353 |
MCF 10A | Seliciclib | 0.12 | uM | LJP5 | 72 | hr | 513 | 9976 | 10401 | 0.9592 | 0.9571 |
MCF 10A | Ruxolitinib | 0.12 | uM | LJP5 | 72 | hr | 513 | 10005 | 10401 | 0.9619 | 0.9599 |
MCF 10A | XL147 | 0.12 | uM | LJP5 | 72 | hr | 513 | 10166 | 10401 | 0.9774 | 0.9763 |
MCF 10A | Saracatinib | 0.12 | uM | LJP6 | 72 | hr | 513 | 9681 | 10401 | 0.9308 | 0.9272 |
MCF 10A | Selumetinib | 0.12 | uM | LJP6 | 72 | hr | 513 | 2200 | 10401 | 0.2116 | 0.1706 |
MCF 10A | Sirolimus | 0.12 | uM | LJP6 | 72 | hr | 513 | 10290 | 10401 | 0.9894 | 0.9888 |
MCF 10A | Sorafenib | 0.12 | uM | LJP6 | 72 | hr | 513 | 10401 | 10401 | 1.0000 | 1.0000 |
MCF 10A | SU11274 | 0.12 | uM | LJP5 | 72 | hr | 513 | 10030 | 10401 | 0.9644 | 0.9625 |
MCF 10A | Fedratinib | 0.12 | uM | LJP5 | 72 | hr | 513 | 9869 | 10401 | 0.9489 | 0.9463 |
MCF 10A | TGX221 | 0.12 | uM | LJP5 | 72 | hr | 513 | 8843 | 10401 | 0.8502 | 0.8424 |
MCF 10A | Torin1 | 0.12 | uM | LJP6 | 72 | hr | 513 | 1397 | 10401 | 0.1343 | 0.0894 |
MCF 10A | Torin2 | 0.12 | uM | LJP5 | 72 | hr | 513 | 505 | 10401 | 0.0486 | -0.0008 |
MCF 10A | Tozasertib | 0.12 | uM | LJP5 | 72 | hr | 513 | 1287 | 10401 | 0.1238 | 0.0783 |
MCF 10A | Trametinib | 0.12 | uM | LJP5 | 72 | hr | 513 | 783 | 10401 | 0.0753 | 0.0273 |